11.05.2011 • Product

Accelrys' Materials Studio: A Comprehensive Materials Modeling and Simulation Application

Photo

Discover how to streamline your innovation cycle and drive better, faster results with Materials Studio - a comprehensive materials modeling and simulation application designed for scientists in chemicals and materials R&D, as well as pharmaceutical development.

With Materials Studio, you can improve product and process quality by rationalizing behavior and designing improvements while reducing costs through "in-silico screening" that focuses experimentation on productive pathways.

Materials Studio reduces the time needed to solve complex calculations with:

  • Industry-leading graphical user environments
  • State-of-the-art simulation technology from quantum to atomistic to mesoscale
  • Powerful statistical tools for structure-property relationships

Materials Studio provides a comprehensive set of scientific capabilities for modeling crystal structure and crystallization processes; for property prediction for molecules, polymers, catalysts, and other materials; and for the development of structure-activity relationships.

With Materials Studio you can:

  • Reduce the number of costly and often lengthy experiments needed to bring a product to market
  • Minimize the time needed to set up and solve complex calculations
  • Make well-informed decisions in research on a wide range of systems including catalysts, polymers, specialty chemicals, advanced materials and drug development

Learn more about Materials Studio:

 

Company

Accelrys Inc. - Corporate Headquarters

10188 Telesis Court, Suite 100
San Diego, CA 92121

Company contact







Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read